Literature DB >> 12351142

Metabolism of N-acetylbenzidine and initiation of bladder cancer.

Terry V Zenser1, Vijaya M Lakshmi, Fong Fu Hsu, Bernard B Davis.   

Abstract

A 100-fold increased incidence of bladder cancer is observed with workers exposed to high levels of benzidine (BZ). This review evaluates the overall metabolism of BZ to determine pathways involved in initiation of carcinogenesis. Enzymatic and liver slice incubations demonstrated N-acetylation and N-glucuronidation of BZ and N-acetylbenzidine (ABZ). With rat, N,N'-diacetylbenzidine (DABZ) is the major slice metabolite. With human, ABZ is the major metabolite along with N-glucuronides. Differences between rat and human are attributed to preferential acetylation of BZ and deacetylation of DABZ, resulting in N-glucuronide formation by human liver. Glucuronidation of BZ and its analogues exhibited the following relative ranking of UDP-glucuronosyltransferase (UGT) metabolism: UGT1A9>UGT1A4>>UGT2B7>UGT1A6 approximately UGT1A1. N-Glucuronides of BZ, ABZ, and N'-hydroxy-N-acetylbenzidine (N'HA) are acid labile with the latter having a much longer t(1/2) than the former two glucuronides. O-Glucuronides are not acid labile. In urine from BZ-exposed workers, an inverse relationship between urine pH and levels of free (unconjugated) BZ and ABZ is observed. This is consistent with the presence of labile urinary N-glucuronides. Cytochrome P-450 oxidizes BZ to an inactive product (3-OHz.sbnd;BZ) and ABZ to N'HA and N-hydroxy-N-acetylbenzidine (NHA). Cytochrome P-450, PHS, and horseradish peroxidase activate ABZ to bind DNA forming N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine (dGp-ABZ). This is the major adduct detected in bladder cells from workers exposed to BZ. An inverse relationship exists between urine pH and levels of bladder cell dGp-ABZ. Bladder epithelium contains relatively high levels of prostaglandin H synthase (PHS) and low levels of cytochrome p-450, suggesting activation by PHS. Activation by PHS involves a peroxygenase oxidation of ABZ to N'HA, while horseradish peroxidase activates ABZ to a diimine monocation. Reactive nitrogen oxygen species (RNOS) offer a new pathway for metabolism and potential activation. Results suggest BZ initiation of bladder cancer is complex, involving multiple organs (i.e. liver, kidney, and bladder) and metabolic pathways (i.e. N-acetylation, N-glucuronidation, peroxidation, and RNOS).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351142     DOI: 10.1016/s0027-5107(02)00149-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

Review 1.  Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens.

Authors:  Yuesheng Zhang
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

2.  Urinary pH, cigarette smoking and bladder cancer risk.

Authors:  Juan Alguacil; Manolis Kogevinas; Debra T Silverman; Núria Malats; Francisco X Real; Montserrat García-Closas; Adonina Tardón; Manuel Rivas; Montserrat Torà; Reina García-Closas; Consol Serra; Alfredo Carrato; Ruth M Pfeiffer; Joan Fortuny; Claudine Samanic; Nathaniel Rothman
Journal:  Carcinogenesis       Date:  2011-03-14       Impact factor: 4.944

3.  UDP-glucuronosyltransferase-mediated metabolic activation of the tobacco carcinogen 2-amino-9H-pyrido[2,3-b]indole.

Authors:  Yijin Tang; David M LeMaster; Gwendoline Nauwelaërs; Dan Gu; Sophie Langouët; Robert J Turesky
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

Review 4.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

5.  Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.

Authors:  Jonine D Figueroa; Núria Malats; Montserrat García-Closas; Francisco X Real; Debra Silverman; Manolis Kogevinas; Stephen Chanock; Robert Welch; Mustafa Dosemeci; Qing Lan; Adonina Tardón; Consol Serra; Alfredo Carrato; Reina García-Closas; Gemma Castaño-Vinyals; Nathaniel Rothman
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

6.  Bladder cancer SNP panel predicts susceptibility and survival.

Authors:  Angeline S Andrew; Jiang Gui; Arthur C Sanderson; Rebecca A Mason; Elaine V Morlock; Alan R Schned; Karl T Kelsey; Carmen J Marsit; Jason H Moore; Margaret R Karagas
Journal:  Hum Genet       Date:  2009-03-01       Impact factor: 4.132

7.  Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history.

Authors:  Hiroki Ide; Eiji Kikuchi; Koichiro Ogihara; Naoya Niwa; Keisuke Shigeta; Tsukasa Masuda; Yuto Baba; Ryuichi Mizuno; Mototsugu Oya
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

8.  Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Authors:  Holger Schwender; Silvia Selinski; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Klaus Golka; Jan G Hengstler
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 9.  Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms?

Authors:  Aleksandra M Dudek; Anne J Grotenhuis; Sita H Vermeulen; Lambertus A L M Kiemeney; Gerald W Verhaegh
Journal:  Int J Mol Sci       Date:  2013-06-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.